Please assess the completion status of the following clinical trial:

Trial Title: A Clinical Investigation of the M2a-Magnum™ Hip System

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Non-inflammatory degenerative joint disease including: Avascular Necrosis, Diastrophic Variant, Fracture of the Pelvis, Fused Hip, Leg Perthes, Osteoarthritis, Slipped Capital Epiphysis, Subcapital Fractures, Traumatic Arthritis~* Rheumatoid Arthritis~* Correction of Functional Deformity~* Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques~* Revision of previously failed total hip arthroplasty~Exclusion Criteria:~Absolute contraindications include:~* Infection, Sepsis, and Osteomyelitis~Relative contraindications include:~* Uncooperative patient or patient with neurologic disorders that are incapable of following directions~* Osteoporosis~* Metabolic disorders which may impair bone formation~* Osteomalacia~* Distant foci of infections which may spread to the implant site~* Rapid joint destruction, marked bone loss, or bone resorption apparent on roentgenogram~* Vascular insufficiency, muscular atrophy, or neuromuscular disease

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- M2a-Magnum™ Hip System (Type: None): Patients who received the M2a-Magnum™ Hip System

Based on this trial design, predict the completion outcome and termination type (if applicable).